We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$568M
AUM Growth
+$55.3M
Cap. Flow
+$7.09M
Cap. Flow %
1.25%
Top 10 Hldgs %
82.48%
Holding
77
New
5
Increased
9
Reduced
4
Closed
4
Avg Time Held
2.9 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
2.5 years

Top Buys

Rank Stock Value
1
KZIA icon
Kazia Therapeutics
KZIA
+$3.41M
2
DTIL icon
Precision BioSciences
DTIL
+$3.33M
3
PXLW icon
Pixelworks
PXLW
+$1.54M
4
GPGI icon
GPGI Inc
GPGI
+$1.1M
5
EYPT icon
EyePoint Inc
EYPT
+$850K

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$3M
2
CMPOW icon
CompoSecure Inc Warrant
CMPOW
+$1.28M
3
FEAM icon
5E Advanced Materials
FEAM
+$997K
4
EVOK icon
Evoke Pharma
EVOK
+$728K
5
GPCR icon
Structure Therapeutics
GPCR
+$408K

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.76%
2 Industrials 28.25%
3 Healthcare 13.73%
4 Technology 6.13%
5 Materials 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$188M 33.12%
475,000
– –
2019 Q4
24 quarters
GPGI icon
2
GPGI Inc
GPGI
$3.59B
$76.6M 13.48%
3,974,676
+55,210
+1% +$1.1M
2022 Q1
15 quarters
RHLD icon
3
Resolute Holdings Management
RHLD
$897M
$66M 11.62%
319,844
-1,569
-0.5% -$232K
2025 Q1
3 quarters
LIN icon
4
Linde
LIN
$229B
$32M 5.64%
75,114
-7,000
-9% -$3M
2019 Q4
24 quarters
MDXH icon
5
MDxHealth
MDXH
$57.8M
$26.3M 4.64%
7,378,333
– –
2021 Q4
16 quarters
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$811B
$22.2M 3.91%
32,570
– –
2023 Q4
8 quarters
DUOT icon
7
Duos Technologies
DUOT
$166M
$18.3M 3.22%
1,627,806
– –
2020 Q1
23 quarters
BX icon
8
Blackstone
BX
$84.5B
$14M 2.46%
90,750
– –
2019 Q4
24 quarters
IDN icon
9
Intellicheck
IDN
$45.6M
$13.9M 2.44%
2,073,583
– –
2019 Q4
24 quarters
INVE icon
10
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$11.1M 1.95%
2,884,495
– –
2019 Q4
24 quarters
SPGI icon
11
S&P Global
SPGI
$123B
$10.5M 1.84%
20,000
– –
2019 Q4
24 quarters
DTIL icon
12
Precision BioSciences
DTIL
$168M
$6.92M 1.22%
1,662,500
+587,500
+55% +$3.33M
2025 Q1
3 quarters
EYPT icon
13
EyePoint Inc
EYPT
$270M
$5.78M 1.02%
316,515
+60,000
+23% +$850K
2025 Q2
2 quarters
IMMX icon
14
Immix Biopharma
IMMX
$727M
$5.23M 0.92%
1,000,000
+150,000
+18% +$617K
2024 Q1
7 quarters
OWLT icon
15
Owlet
OWLT
$128M
$5.02M 0.88%
310,000
+40,000
+15% +$453K
2024 Q3
5 quarters
JPM icon
16
JPMorgan Chase
JPM
$886B
$4.83M 0.85%
15,000
– –
2019 Q4
24 quarters
LIQT icon
17
LiqTech
LIQT
$11.9M
$4.65M 0.82%
3,182,239
– –
2020 Q1
23 quarters
PROK icon
18
ProKidney
PROK
$307M
$4.48M 0.79%
2,000,000
– –
2022 Q3
13 quarters
BRFH icon
19
Barfresh Food Group
BRFH
$11M
$4.07M 0.72%
1,390,758
– –
2022 Q1
15 quarters
WELL icon
20
Welltower
WELL
$169B
$3.71M 0.65%
20,000
– –
2025 Q2
2 quarters
FLNT icon
21
Fluent
FLNT
$82.2M
$3.43M 0.6%
1,428,571
– –
2025 Q3
1 quarter
GNLX icon
22
Genelux
GNLX
$110M
$3.11M 0.55%
714,000
– –
2025 Q1
3 quarters
DMAC icon
23
DiaMedica Therapeutics
DMAC
$425M
$3.04M 0.54%
382,317
– –
2023 Q2
10 quarters
NMTC icon
24
NeuroOne Medical Technologies
NMTC
$9.65M
$3.03M 0.53%
666,667
– –
2025 Q2
2 quarters
TV icon
25
Televisa
TV
$1.28B
$3M 0.53%
1,030,000
– –
2021 Q2
18 quarters
1
2 3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q4 2025 Portfolio in Review

As of Q4 2025, Bleichroeder LP held 77 positions worth $568M, up 11% from $513M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2025 filing shows 5 new, 9 increased, 4 reduced and 4 closed positions. Its largest new stake was Kazia Therapeutics: 400,000 shares worth $2.76M. The largest sale was Linde, an estimated $3M.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q4 2025 buy was Kazia Therapeutics: 400,000 shares worth $2.76M.
  • Bleichroeder LP added most to Precision BioSciences in Q4 2025, an estimated $3.33M increase.
  • Bleichroeder LP's biggest Q4 2025 reduction was Linde, cutting an estimated $3M.
  • Bleichroeder LP fully exited CompoSecure Inc Warrant in Q4 2025, selling an estimated $1.28M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $568M portfolio in Q4 2025.
  • Bleichroeder LP opened 5 new positions and closed 4 in Q4 2025.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $568M.

Based on Bleichroeder LP's 13F filing for Q4 2025, filed 13 Feb 2026.